A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients

By Iwata Hiroji   Narabayashi Masaru   Ito Yoshinori   Saji Shigehira   Fujiwara Yasuhiro   Usami Shigeyuki   Katsura Koichi   Sasaki Yasutsuna  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite

Isolated brain metastases as the sole manifestation of a late relapse in breast cancer

By Issa Charbel   Semrau R.   Kath R.   Höffken K.  

Journal of Cancer Research and Clinical Oncology, Vol. 128, Iss. 1, 2002-01 ,pp. : 61-63

Springer Publishing Company

Access to resources Recommend Favorite

Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy

By Baek Ji  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 745-753

Springer Publishing Company

Access to resources Recommend Favorite

Use of liposomal doxorubicin–cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study

By Linot B.   Campone M.   Augereau P.   Delva R.   Abadie-Lacourtoisie S.   Nebout-Mesgouez N.   Capitain O.  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 253-259

Springer Publishing Company

Access to resources Recommend Favorite

EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases

By Luo Dongdong   Ye Xin   Hu Zheng   Peng Kaiwen   Song Ye   Yin Xiaolu   Zhu Guanshan   Ji Qunsheng   Peng Yuping  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2437-2444

Springer Publishing Company

Access to resources Recommend Favorite